{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:00:32Z","timestamp":1790251232900,"version":"4.1.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"38","license":[{"start":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T00:00:00Z","timestamp":1495411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T00:00:00Z","timestamp":1495411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,9,21]]},"DOI":"10.1038\/onc.2017.116","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T09:13:20Z","timestamp":1495530800000},"page":"5341-5355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms"],"prefix":"10.1038","volume":"36","author":[{"given":"C","family":"Unger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Unterleuthner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Scherzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Burian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rudisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schlederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Lenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Wernitznig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Kenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hengstschl\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sch\u00fcler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Sommergruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6063-3585","authenticated-orcid":false,"given":"H","family":"Dolznig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,22]]},"reference":[{"key":"BFonc2017116_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A . Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5\u201329.","journal-title":"CA Cancer J Clin"},{"key":"BFonc2017116_CR2","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(10)60353-4","volume":"375","author":"D Cunningham","year":"2010","unstructured":"Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B et al. Colorectal cancer. Lancet 2010; 375: 1030\u20131047.","journal-title":"Lancet"},{"key":"BFonc2017116_CR3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3215","volume":"12","author":"M Pollak","year":"2012","unstructured":"Pollak M . The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer 2012; 12: 159\u2013169.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2017116_CR4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak M . Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008; 8: 915\u2013928.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2017116_CR5","doi-asserted-by":"crossref","first-page":"e103551","DOI":"10.1371\/journal.pone.0103551","volume":"9","author":"J Lee","year":"2014","unstructured":"Lee J, Jain A, Kim P, Lee T, Kuller A, Princen F et al. Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational status. PLoS ONE 2014; 9: e103551.","journal-title":"PLoS ONE"},{"key":"BFonc2017116_CR6","doi-asserted-by":"crossref","first-page":"272ra12","DOI":"10.1126\/scitranslmed.3010445","volume":"7","author":"ER Zanella","year":"2015","unstructured":"Zanella ER, Galimi F, Sassi F, Migliardi G, Cottino F, Leto SM et al. IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. Sci Transl Med 2015; 7: 272ra12.","journal-title":"Sci Transl Med"},{"key":"BFonc2017116_CR7","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1053\/j.gastro.2010.07.050","volume":"139","author":"Y Baba","year":"2010","unstructured":"Baba Y, Nosho K, Shima K, Huttenhower C, Tanaka N, Hazra A et al. Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis. Gastroenterology 2010; 139: 1855\u20131864.","journal-title":"Gastroenterology"},{"key":"BFonc2017116_CR8","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1158\/1078-0432.CCR-07-4879","volume":"14","author":"MM Chitnis","year":"2008","unstructured":"Chitnis MM, Yuen JS, Protheroe AS, Pollak M, Macaulay VM . The type 1 insulin-like growth factor receptor pathway. Clin Cancer Res 2008; 14: 6364\u20136370.","journal-title":"Clin Cancer Res"},{"issue":"Suppl 1","key":"BFonc2017116_CR9","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1677\/erc.1.01280","volume":"13","author":"J Riedemann","year":"2006","unstructured":"Riedemann J, Macaulay VM . IGF1R signalling and its inhibition. Endocr Relat Cancer 2006; 13 (Suppl 1): S33\u2013S43.","journal-title":"Endocr Relat Cancer"},{"key":"BFonc2017116_CR10","doi-asserted-by":"crossref","first-page":"11217","DOI":"10.1073\/pnas.90.23.11217","volume":"90","author":"C Sell","year":"1993","unstructured":"Sell C, Rubini M, Rubin R, Liu JP, Efstratiadis A, Baserga R . Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl Acad Sci USA 1993; 90: 11217\u201311221.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017116_CR11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/mp.54.3.133","volume":"54","author":"B Valentinis","year":"2001","unstructured":"Valentinis B, Baserga R . IGF-I receptor signalling in transformation and differentiation. Mol Pathol 2001; 54: 133\u2013137.","journal-title":"Mol Pathol"},{"key":"BFonc2017116_CR12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"Network CGA","year":"2012","unstructured":"Network CGA. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487: 330\u2013337.","journal-title":"Nature"},{"key":"BFonc2017116_CR13","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.276.5316.1268","volume":"276","author":"L Zhang","year":"1997","unstructured":"Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR et al. Gene expression profiles in normal and cancer cells. Science 1997; 276: 1268\u20131272.","journal-title":"Science"},{"key":"BFonc2017116_CR14","doi-asserted-by":"crossref","first-page":"R321","DOI":"10.1530\/ERC-13-0231","volume":"20","author":"C Livingstone","year":"2013","unstructured":"Livingstone C . IGF2 and cancer. Endocr Relat Cancer 2013; 20: R321\u2013R339.","journal-title":"Endocr Relat Cancer"},{"key":"BFonc2017116_CR15","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1126\/science.1080902","volume":"299","author":"H Cui","year":"2003","unstructured":"Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003; 299: 1753\u20131755.","journal-title":"Science"},{"key":"BFonc2017116_CR16","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1158\/0008-5472.CAN-05-2959","volume":"65","author":"A Kaneda","year":"2005","unstructured":"Kaneda A, Feinberg AP . Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk. Cancer Res 2005; 65: 11236\u201311240.","journal-title":"Cancer Res"},{"key":"BFonc2017116_CR17","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1126\/science.1108080","volume":"307","author":"T Sakatani","year":"2005","unstructured":"Sakatani T, Kaneda A, Iacobuzio-Donahue CA, Carter MG, de Boom Witzel S, Okano H et al. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science 2005; 307: 1976\u20131978.","journal-title":"Science"},{"key":"BFonc2017116_CR18","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1158\/0008-5472.CAN-05-2036","volume":"66","author":"J Harper","year":"2006","unstructured":"Harper J, Burns JL, Foulstone EJ, Pignatelli M, Zaina S, Hassan AB . Soluble IGF2 receptor rescues Apc(Min\/+) intestinal adenoma progression induced by Igf2 loss of imprinting. Cancer Res 2006; 66: 1940\u20131948.","journal-title":"Cancer Res"},{"key":"BFonc2017116_CR19","first-page":"2448","volume":"55","author":"C Singer","year":"1995","unstructured":"Singer C, Rasmussen A, Smith HS, Lippman ME, Lynch HT, Cullen KJ . Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function. Cancer Res 1995; 55: 2448\u20132454.","journal-title":"Cancer Res"},{"key":"BFonc2017116_CR20","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1038\/onc.2011.526","volume":"31","author":"DN Church","year":"2012","unstructured":"Church DN, Phillips BR, Stuckey DJ, Barnes DJ, Buffa FM, Manek S et al. Igf2 ligand dependency of Pten(+\/\u2212) developmental and tumour phenotypes in the mouse. Oncogene 2012; 31: 3635\u20133646.","journal-title":"Oncogene"},{"key":"BFonc2017116_CR21","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1038\/ncomms4472","volume":"5","author":"WJ Chen","year":"2014","unstructured":"Chen WJ, Ho CC, Chang YL, Chen HY, Lin CA, Ling TY et al. Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling. Nat Commun 2014; 5: 3472.","journal-title":"Nat Commun"},{"key":"BFonc2017116_CR22","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M . Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392\u2013401.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2017116_CR23","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/onc.2014.18","volume":"34","author":"C Rupp","year":"2015","unstructured":"Rupp C, Scherzer M, Rudisch A, Unger C, Haslinger C, Schweifer N et al. IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor-stroma interaction. Oncogene 2015; 34: 815\u2013825.","journal-title":"Oncogene"},{"key":"BFonc2017116_CR24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1593\/neo.07112","volume":"9","author":"DR Rhodes","year":"2007","unstructured":"Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18\u2009000 cancer gene expression profiles. Neoplasia 2007; 9: 166\u2013180.","journal-title":"Neoplasia"},{"key":"BFonc2017116_CR25","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1158\/1078-0432.CCR-11-1078","volume":"18","author":"N Nishida","year":"2012","unstructured":"Nishida N, Nagahara M, Sato T, Mimori K, Sudo T, Tanaka F et al. Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters. Clin Cancer Res 2012; 18: 3054\u20133070.","journal-title":"Clin Cancer Res"},{"key":"BFonc2017116_CR26","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0016-5085(98)70428-7","volume":"114","author":"P Singh","year":"1998","unstructured":"Singh P, Dai B, Given RL, Lu X, Holthuizen PE . Differential activation of IGF-II promoters P3 and P4 in Caco-2 cells during growth and differentiation. Gastroenterology 1998; 114: 1221\u20131229.","journal-title":"Gastroenterology"},{"key":"BFonc2017116_CR27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.yexcr.2015.09.016","volume":"338","author":"H Wang","year":"2015","unstructured":"Wang H, Ge S, Qian G, Li W, Cui J, Wang G et al. Restoration of IGF2 imprinting by polycomb repressive complex 2 docking factor SUZ12 in colon cancer cells. Exp Cell Res 2015; 338: 214\u2013221.","journal-title":"Exp Cell Res"},{"key":"BFonc2017116_CR28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1074\/jbc.M112.432013","volume":"288","author":"SA Greenall","year":"2013","unstructured":"Greenall SA, Bentley JD, Pearce LA, Scoble JA, Sparrow LG, Bartone NA et al. Biochemical characterization of individual human glycosylated pro-insulin-like growth factor (IGF)-II and big-IGF-II isoforms associated with cancer. J Biol Chem 2013; 288: 59\u201368.","journal-title":"J Biol Chem"},{"key":"BFonc2017116_CR29","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/0008-5472.CAN-10-2274","volume":"71","author":"J Gao","year":"2011","unstructured":"Gao J, Chesebrough JW, Cartlidge SA, Ricketts SA, Incognito L, Veldman-Jones M et al. Dual IGF-I\/II-neutralizing antibody MEDI-573 potently inhibits IGF signaling and tumor growth. Cancer Res 2011; 71: 1029\u20131040.","journal-title":"Cancer Res"},{"key":"BFonc2017116_CR30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/bjc.2011.263","volume":"105","author":"JS Liles","year":"2011","unstructured":"Liles JS, Arnoletti JP, Kossenkov AV, Mikhaylina A, Frost AR, Kulesza P et al. Targeting ErbB3-mediated stromal-epithelial interactions in pancreatic ductal adenocarcinoma. Br J Cancer 2011; 105: 523\u2013533.","journal-title":"Br J Cancer"},{"key":"BFonc2017116_CR31","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nature11183","volume":"487","author":"R Straussman","year":"2012","unstructured":"Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 2012; 487: 500\u2013504.","journal-title":"Nature"},{"key":"BFonc2017116_CR32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/gutjnl-2011-301393","volume":"62","author":"A De Boeck","year":"2013","unstructured":"De Boeck A, Pauwels P, Hensen K, Rummens JL, Westbroek W, Hendrix A et al. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1\/HER3 signalling. Gut 2013; 62: 550\u2013560.","journal-title":"Gut"},{"key":"BFonc2017116_CR33","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1096\/fj.03-1110fje","volume":"18","author":"O De Wever","year":"2004","unstructured":"De Wever O, Nguyen QD, Van Hoorde L, Bracke M, Bruyneel E, Gespach C et al. Tenascin-C and SF\/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J 2004; 18: 1016\u20131018.","journal-title":"FASEB J"},{"key":"BFonc2017116_CR34","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1038\/ncomms8002","volume":"6","author":"E Medico","year":"2015","unstructured":"Medico E, Russo M, Picco G, Cancelliere C, Valtorta E, Corti G et al. The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets. Nat Commun 2015; 6: 7002.","journal-title":"Nat Commun"},{"key":"BFonc2017116_CR35","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1101\/gad.11.6.701","volume":"11","author":"SG Kennedy","year":"1997","unstructured":"Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN et al. The PI 3-kinase\/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 1997; 11: 701\u2013713.","journal-title":"Genes Dev"},{"key":"BFonc2017116_CR36","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC . AKT\/PKB signaling: navigating downstream. Cell 2007; 129: 1261\u20131274.","journal-title":"Cell"},{"key":"BFonc2017116_CR37","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/ncb1658","volume":"9","author":"C Gaggioli","year":"2007","unstructured":"Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007; 9: 1392\u20131400.","journal-title":"Nat Cell Biol"},{"key":"BFonc2017116_CR38","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/ijc.23925","volume":"123","author":"O De Wever","year":"2008","unstructured":"De Wever O, Demetter P, Mareel M, Bracke M . Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 2008; 123: 2229\u20132238.","journal-title":"Int J Cancer"},{"key":"BFonc2017116_CR39","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","volume":"170","author":"B Hinz","year":"2007","unstructured":"Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G . The myofibroblast: one function, multiple origins. Am J Pathol 2007; 170: 1807\u20131816.","journal-title":"Am J Pathol"},{"key":"BFonc2017116_CR40","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1091\/mbc.12.9.2730","volume":"12","author":"B Hinz","year":"2001","unstructured":"Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C . Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 2001; 12: 2730\u20132741.","journal-title":"Mol Biol Cell"},{"key":"BFonc2017116_CR41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1083\/jcb.122.1.103","volume":"122","author":"A Desmouliere","year":"1993","unstructured":"Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G . Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993; 122: 103\u2013111.","journal-title":"J Cell Biol"},{"key":"BFonc2017116_CR42","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1349-7006.2005.00103.x","volume":"96","author":"M Tojo","year":"2005","unstructured":"Tojo M, Hamashima Y, Hanyu A, Kajimoto T, Saitoh M, Miyazono K et al. The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta. Cancer Sci 2005; 96: 791\u2013800.","journal-title":"Cancer Sci"},{"key":"BFonc2017116_CR43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0002-9440(10)65334-5","volume":"154","author":"PD Arora","year":"1999","unstructured":"Arora PD, Narani N, McCulloch CA . The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol 1999; 154: 871\u2013882.","journal-title":"Am J Pathol"},{"key":"BFonc2017116_CR44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1101\/gad.828901","volume":"15","author":"B Elenbaas","year":"2001","unstructured":"Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 2001; 15: 50\u201365.","journal-title":"Genes Dev"},{"key":"BFonc2017116_CR45","doi-asserted-by":"crossref","first-page":"e1001453","DOI":"10.1371\/journal.pmed.1001453","volume":"10","author":"L Marisa","year":"2013","unstructured":"Marisa L, de Reynies A, Duval A, Selves J, Gaub MP, Vescovo L et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med 2013; 10: e1001453.","journal-title":"PLoS Med"},{"key":"BFonc2017116_CR46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1755-8794-4-9","volume":"4","author":"A Loboda","year":"2011","unstructured":"Loboda A, Nebozhyn MV, Watters JW, Buser CA, Shaw PM, Huang PS et al. EMT is the dominant program in human colon cancer. BMC Med Genomics 2011; 4: 9.","journal-title":"BMC Med Genomics"},{"key":"BFonc2017116_CR47","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ccr.2012.08.013","volume":"22","author":"A Calon","year":"2012","unstructured":"Calon A, Espinet E, Palomo-Ponce S, Tauriello DV, Iglesias M, Cespedes MV et al. Dependency of colorectal cancer on a TGF-beta-driven program in stromal cells for metastasis initiation. Cancer Cell 2012; 22: 571\u2013584.","journal-title":"Cancer Cell"},{"key":"BFonc2017116_CR48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell 2005; 121: 335\u2013348.","journal-title":"Cell"},{"key":"BFonc2017116_CR49","first-page":"5002","volume":"59","author":"AF Olumi","year":"1999","unstructured":"Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR . Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999; 59: 5002\u20135011.","journal-title":"Cancer Res"},{"key":"BFonc2017116_CR50","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng.3225","volume":"47","author":"A Calon","year":"2015","unstructured":"Calon A, Lonardo E, Berenguer-Llergo A, Espinet E, Hernando-Momblona X, Iglesias M et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat Genet 2015; 47: 320\u2013329.","journal-title":"Nat Genet"},{"key":"BFonc2017116_CR51","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng.3224","volume":"47","author":"C Isella","year":"2015","unstructured":"Isella C, Terrasi A, Bellomo SE, Petti C, Galatola G, Muratore A et al. Stromal contribution to the colorectal cancer transcriptome. Nat Genet 2015; 47: 312\u2013319.","journal-title":"Nat Genet"},{"key":"BFonc2017116_CR52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ghir.2006.05.003","volume":"16","author":"I Fukuda","year":"2006","unstructured":"Fukuda I, Hizuka N, Ishikawa Y, Yasumoto K, Murakami Y, Sata A et al. Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia. Growth Horm IGF Res 2006; 16: 211\u2013216.","journal-title":"Growth Horm IGF Res"},{"key":"BFonc2017116_CR53","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1677\/ERC-07-0161","volume":"14","author":"JW de Groot","year":"2007","unstructured":"de Groot JW, Rikhof B, van Doorn J, Bilo HJ, Alleman MA, Honkoop AH et al. Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases. Endocr Relat Cancer 2007; 14: 979\u2013993.","journal-title":"Endocr Relat Cancer"},{"key":"BFonc2017116_CR54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/08977190802057258","volume":"26","author":"SK Singh","year":"2008","unstructured":"Singh SK, Moretta D, Almaguel F, De Leon M, De Leon DD . Precursor IGF-II (proIGF-II) and mature IGF-II (mIGF-II) induce Bcl-2 And Bcl-X L expression through different signaling pathways in breast cancer cells. Growth Factors 2008; 26: 92\u2013103.","journal-title":"Growth Factors"},{"key":"BFonc2017116_CR55","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","volume":"9","author":"JA Engelman","year":"2009","unstructured":"Engelman JA . Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 2009; 9: 550\u2013562.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2017116_CR56","doi-asserted-by":"crossref","first-page":"e0124283","DOI":"10.1371\/journal.pone.0124283","volume":"10","author":"A Rudisch","year":"2015","unstructured":"Rudisch A, Dewhurst MR, Horga LG, Kramer N, Harrer N, Dong M et al. High EMT signature score of invasive non-small cell lung cancer (NSCLC) cells correlates with NFkappaB driven colony-stimulating factor 2 (CSF2\/GM-CSF) secretion by neighboring stromal fibroblasts. PLoS ONE 2015; 10: e0124283.","journal-title":"PLoS ONE"},{"key":"BFonc2017116_CR57","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1158\/0008-5472.CAN-08-0280","volume":"68","author":"YP Hu","year":"2008","unstructured":"Hu YP, Patil SB, Panasiewicz M, Li W, Hauser J, Humphrey LE et al. Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor. Cancer Res 2008; 68: 8004\u20138013.","journal-title":"Cancer Res"},{"key":"BFonc2017116_CR58","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cell.2011.05.040","volume":"146","author":"JG Goetz","year":"2011","unstructured":"Goetz JG, Minguet S, Navarro-Lerida I, Lazcano JJ, Samaniego R, Calvo E et al. Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 2011; 146: 148\u2013163.","journal-title":"Cell"},{"key":"BFonc2017116_CR59","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"KR Levental","year":"2009","unstructured":"Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009; 139: 891\u2013906.","journal-title":"Cell"},{"key":"BFonc2017116_CR60","first-page":"21","volume":"63","author":"I Darby","year":"1990","unstructured":"Darby I, Skalli O, Gabbiani G . Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990; 63: 21\u201329.","journal-title":"Lab Invest"},{"key":"BFonc2017116_CR61","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bbrc.2005.10.209","volume":"339","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Liu X, Wen FQ, Kohyama T, Shen L, Wang XQ et al. Smad3 mediates TGF-beta1-induced collagen gel contraction by human lung fibroblasts. Biochem Biophys Res Commun 2006; 339: 290\u2013295.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2017116_CR62","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/annonc\/mdt593","volume":"25","author":"JH Park","year":"2014","unstructured":"Park JH, Richards CH, McMillan DC, Horgan PG, Roxburgh CS . The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer. Ann Oncol 2014; 25: 644\u2013651.","journal-title":"Ann Oncol"},{"key":"BFonc2017116_CR63","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1158\/1078-0432.CCR-06-2191","volume":"13","author":"T Tsujino","year":"2007","unstructured":"Tsujino T, Seshimo I, Yamamoto H, Ngan CY, Ezumi K, Takemasa I et al. Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res 2007; 13: 2082\u20132090.","journal-title":"Clin Cancer Res"},{"key":"BFonc2017116_CR64","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.bbadis.2013.04.018","volume":"1832","author":"C Raykha","year":"2013","unstructured":"Raykha C, Crawford J, Gan BS, Fu P, Bach LA, O'Gorman DB . IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren's disease. Biochim Biophys Acta 2013; 1832: 1511\u20131519.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc2017116_CR65","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1091\/mbc.e11-04-0335","volume":"22","author":"E Charbonney","year":"2011","unstructured":"Charbonney E, Speight P, Masszi A, Nakano H, Kapus A . Beta-catenin and Smad3 regulate the activity and stability of myocardin-related transcription factor during epithelial-myofibroblast transition. Mol Biol Cell 2011; 22: 4472\u20134485.","journal-title":"Mol Biol Cell"},{"key":"BFonc2017116_CR66","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0002-9440(10)63247-6","volume":"165","author":"A Masszi","year":"2004","unstructured":"Masszi A, Fan L, Rosivall L, McCulloch CA, Rotstein OD, Mucsi I et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol 2004; 165: 1955\u20131967.","journal-title":"Am J Pathol"},{"key":"BFonc2017116_CR67","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s12265-012-9397-0","volume":"5","author":"EM Small","year":"2012","unstructured":"Small EM . The actin-MRTF-SRF gene regulatory axis and myofibroblast differentiation. J Cardiovasc Transl Res 2012; 5: 794\u2013804.","journal-title":"J Cardiovasc Transl Res"},{"key":"BFonc2017116_CR68","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.200106139","volume":"155","author":"S Taya","year":"2001","unstructured":"Taya S, Inagaki N, Sengiku H, Makino H, Iwamatsu A, Urakawa I et al. Direct interaction of insulin-like growth factor-1 receptor with leukemia-associated RhoGEF. J Cell Biol 2001; 155: 809\u2013820.","journal-title":"J Cell Biol"},{"key":"BFonc2017116_CR69","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.celrep.2014.04.036","volume":"7","author":"J Albrengues","year":"2014","unstructured":"Albrengues J, Bourget I, Pons C, Butet V, Hofman P, Tartare-Deckert S et al. LIF mediates proinvasive activation of stromal fibroblasts in cancer. Cell Rep 2014; 7: 1664\u20131678.","journal-title":"Cell Rep"},{"key":"BFonc2017116_CR70","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1479-5876-11-110","volume":"11","author":"BL Hylander","year":"2013","unstructured":"Hylander BL, Punt N, Tang H, Hillman J, Vaughan M, Bshara W et al. Origin of the vasculature supporting growth of primary patient tumor xenografts. J Transl Med 2013; 11: 110.","journal-title":"J Transl Med"},{"key":"BFonc2017116_CR71","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc2627","volume":"9","author":"CA Klein","year":"2009","unstructured":"Klein CA . Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009; 9: 302\u2013312.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2017116_CR72","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1158\/1078-0432.CCR-11-0998","volume":"18","author":"M Pollak","year":"2012","unstructured":"Pollak M . The insulin receptor\/insulin-like growth factor receptor family as a therapeutic target in oncology. Clin Cancer Res 2012; 18: 40\u201350.","journal-title":"Clin Cancer Res"},{"key":"BFonc2017116_CR73","doi-asserted-by":"crossref","first-page":"10791","DOI":"10.1073\/pnas.0914076107","volume":"107","author":"DB Ulanet","year":"2010","unstructured":"Ulanet DB, Ludwig DL, Kahn CR, Hanahan D . Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy. Proc Natl Acad Sci USA 2010; 107: 10791\u201310798.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017116_CR74","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1158\/1535-7163.MCT-10-0318","volume":"9","author":"E Buck","year":"2010","unstructured":"Buck E, Gokhale PC, Koujak S, Brown E, Eyzaguirre A, Tao N et al. Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer. Mol Cancer Ther 2010; 9: 2652\u20132664.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2017116_CR75","doi-asserted-by":"crossref","first-page":"e100165","DOI":"10.1371\/journal.pone.0100165","volume":"9","author":"J Brouwer-Visser","year":"2014","unstructured":"Brouwer-Visser J, Lee J, McCullagh K, Cossio MJ, Wang Y, Huang GS . Insulin-like growth factor 2 silencing restores taxol sensitivity in drug resistant ovarian cancer. PLoS ONE 2014; 9: e100165.","journal-title":"PLoS ONE"},{"key":"BFonc2017116_CR76","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1158\/1535-7163.MCT-13-0598","volume":"13","author":"K Friedbichler","year":"2014","unstructured":"Friedbichler K, Hofmann MH, Kroez M, Ostermann E, Lamche HR, Koessl C et al. Pharmacodynamic and antineoplastic activity of BI 836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale for combination with rapamycin. Mol Cancer Ther 2014; 13: 399\u2013409.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2017116_CR77","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajpath.2011.03.015","volume":"179","author":"H Dolznig","year":"2011","unstructured":"Dolznig H, Rupp C, Puri C, Haslinger C, Schweifer N, Wieser E et al. Modeling colon adenocarcinomas in vitro a 3D co-culture system induces cancer-relevant pathways upon tumor cell and stromal fibroblast interaction. Am J Pathol 2011; 179: 487\u2013501.","journal-title":"Am J Pathol"},{"key":"BFonc2017116_CR78","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/gng015","volume":"31","author":"RA Irizarry","year":"2003","unstructured":"Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP . Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003; 31: e15.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2017116_CR79","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","volume":"4","author":"RA Irizarry","year":"2003","unstructured":"Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249\u2013264.","journal-title":"Biostatistics"},{"key":"BFonc2017116_CR80","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","volume":"19","author":"BM Bolstad","year":"2003","unstructured":"Bolstad BM, Irizarry RA, Astrand M, Speed TP . A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19: 185\u2013193.","journal-title":"Bioinformatics"},{"key":"BFonc2017116_CR81","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1093\/nar\/gni179","volume":"33","author":"M Dai","year":"2005","unstructured":"Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG et al. Evolving gene\/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 2005; 33: e175.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2017116_CR82","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015; 43: e47.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2017116_CR83","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545\u201315550.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017116_CR84","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nprot.2010.74","volume":"5","author":"M Rosner","year":"2010","unstructured":"Rosner M, Siegel N, Fuchs C, Slabina N, Dolznig H, Hengstschlager M . Efficient siRNA-mediated prolonged gene silencing in human amniotic fluid stem cells. Nat Protoc 2010; 5: 1081\u20131095.","journal-title":"Nat Protoc"},{"key":"BFonc2017116_CR85","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0976-500X.119726","volume":"4","author":"J Charan","year":"2013","unstructured":"Charan J, Kantharia ND . How to calculate sample size in animal studies? J Pharmacol Pharmacother 2013; 4: 303\u2013306.","journal-title":"J Pharmacol Pharmacother"},{"key":"BFonc2017116_CR86","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1186\/1471-2407-14-970","volume":"14","author":"CP Goswami","year":"2014","unstructured":"Goswami CP, Nakshatri H . PROGgeneV2: enhancements on the existing database. BMC Cancer 2014; 14: 970.","journal-title":"BMC Cancer"},{"key":"BFonc2017116_CR87","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1158\/1078-0432.CCR-09-1431","volume":"15","author":"RN Jorissen","year":"2009","unstructured":"Jorissen RN, Gibbs P, Christie M, Prakash S, Lipton L, Desai J et al. Metastasis-associated gene expression changes predict poor outcomes in patients with Dukes stage B and C colorectal cancer. Clin Cancer Res 2009; 15: 7642\u20137651.","journal-title":"Clin Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2017116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2017116","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2017.116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/onc2017116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:23:27Z","timestamp":1647894207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2017116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,22]]},"references-count":87,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2017,9,21]]}},"alternative-id":["BFonc2017116"],"URL":"https:\/\/doi.org\/10.1038\/onc.2017.116","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,22]]},"assertion":[{"value":"19 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}